6-Diazo-5-oxo-L-norleucine - LabNet Biotecnica
Feasibility and antitumor efficacy in vivo, of simultaneously targeting glycolysis, glutaminolysis and fatty acid synthesis using lonidamine, 6‑ diazo‑5‑oxo‑L‑norleucine and orlistat in colon cancer
6-Diazo-5-oxo-L-norleucine - Wikipedia
Protective Effects of Glutamine Antagonist 6-Diazo-5-Oxo-l-Norleucine in Mice with Alphavirus Encephalomyelitis | Journal of Virology
Unbiased Metabolic Profiling Predicts Sensitivity of High MYC-Expressing Atypical Teratoid/Rhabdoid Tumors to Glutamine Inhibition with 6-Diazo-5-Oxo -L-Norleucine. - Abstract - Europe PMC
N-(Pivaloyloxy)alkoxy-carbonyl Prodrugs of the Glutamine Antagonist 6-Diazo- 5-oxo-l-norleucine (DON) as a Potential Treatment for HIV Associated Neurocognitive Disorders | Journal of Medicinal Chemistry
Glutamine deficiency induces DNA alkylation damage and sensitizes cancer cells to alkylating agents through inhibition of ALKBH enzymes | PLOS Biology
6-Diazo-5-oxo-L-Norleucine | VWR
6-Diazo-5-oxo-L-norleucine | CAS 157-03-9 | SCBT - Santa Cruz Biotechnology
WO2016112386A1 - Methods for bioanalysis of 6-diazo-5-oxo-l-norleucine (don) and other glutamine antagonists - Google Patents
The combination of orlistat, lonidamine and 6‑diazo‑5‑oxo‑L‑norleucine induces a quiescent energetic phenotype and limits substrate flexibility in colon cancer cells
6-Diazo-5-oxo-L-norleucine (CAS 157-03-9) | Glentham Life Sciences
6-diazo-5-oxo-L-nor-Leucine (DON, NSC 7365, CAS Number: 157-03-9) | Cayman Chemical
6-Diazo-5-oxo-L-norleucine for Sale from Quality Suppliers - ECHEMI
6-Diazo-5-oxo-L-norleucine | C6H9N3O3 | ChemSpider
6-Diazo-5-oxo-L-norleucine-cancer research-TOKU-E
157-03-9 | 6-Diazo-5-oxo-L-norleucine | = 99% (Assay by titration) - Chem-Impex International
Model studies towards prodrugs of the glutamine antagonist 6-diazo-5-oxo-l- norleucine (DON) containing a diazo precursor - ScienceDirect
Tumor-Targeted Delivery of 6-Diazo-5-oxo-l-norleucine (DON) Using Substituted Acetylated Lysine Prodrugs | Journal of Medicinal Chemistry
6 Diazo 5 Oxonorleucine - an overview | ScienceDirect Topics
WO2016112386A1 - Methods for bioanalysis of 6-diazo-5-oxo-l-norleucine (don) and other glutamine antagonists - Google Patents
6-Diazo-5-oxo-L-norleucine - Wikipedia
6-Diazo-5-oxo-L-norleucine ≥98.0% (UV) | Sigma-Aldrich
6-Diazo-5-oxo-L-norleucine ≥98.0% (UV) | Sigma-Aldrich
Tumor-Targeted Delivery of 6-Diazo-5-oxo-l-norleucine (DON) Using Substituted Acetylated Lysine Prodrugs | Journal of Medicinal Chemistry
Chemical structure of 6-diazo-5-oxo-l-norleucine (DON) and the prodrug... | Download Scientific Diagram
a U251 were treated with l-asparaginase and/or... | Download Scientific Diagram
6-Diazo-5-oxo-L-norleucine - Wikipedia
